10% Discount on Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market (Valid Till 30th Sept 2016)

Bharatbook.com announces a report on “Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2019 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment”. Key strengths, weaknesses and threats influencing leading player position within the market. https://www.bharatbook.com/healthcare-market-research-reports-433355/personalized-medicine-targeted-therapeutics-companion-diagnostic.html

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by over 360 tables & figures over 393 pages. The Personalized Medicine (global & USA) market is presented as follows:

• By Company (e.g., Qiagen, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode /Amgen, CELERA, MYRIAD)

• By Segment (Targeted therapeutics, Companion Diagnostics, Liquid Biopsies)

• By Sub-market (Companion diagnostic, targeted cancer therapeutic, medical technology, pharmacogenomics, consumer genomics, molecular diagnostics, liquid biopsy) • By Therapy (Cancer, Cardiovascular, Infectious Disease)

Key Opinion Leaders that contributed to interview questions within the report include:

• Iain D. Miller, PhD, MBA, Founder & CEO, Healthcare Strategies Group

• Stephen Finn, MBBS, PhD, Associate Professor, Cancer Molecular Diagnostic Laboratory, Consultant Histopathologist and Head of Histopathology, St James’s Hospital and Trinity College Dublin, Ireland

• Ronald Przygodzki, MD, Director, Genomic Medicine Implementation at U.S. Department of Veterans Affairs, Washington DC

• Elaine Kenny, PhD, Founder, Elda Biotech, Dublin 2, Ireland

• Chad Clark, Co-President and Chief Operating Officer, Precision for Medicine

• Tobias Guennel, PhD, Principal, Biomarker and IVD Analytics, Precision for Medicine

• David Parker, PhD, Vice President, Integrated Market Access, Precision for Medicine

• Deborah Phippard, PhD, Vice President, Research,...